BUSINESS BRIEF

Pharma company in the field of manufacturing APIs for Therapeutic drugs and Intermediates, R&D, Custom Synthesis is looking to raise funds to restart its operations. The firm has always focused on complicated chemistries and specialty products and manufactures various Therapeutic drugs including Anti-Parkinson, Anti-Ulcerative, Anti-Asthmatic, Anti Bacterial, etc. The firm has 2 units and to set up a second plant for which they took a loan from Bank but did not get the clearance due to the vested interest of the local government. It took 26 months to get clearance from the Local government. At the same time, an untimely separate state agitation happened and non-co-operation from banks led to the company becoming NPA. That's why sales are 0.

Business Divisions

Therapeutic Drugs Mnfcting

Products & Services

Therapeutic Drugs, R&D, Custom Synthesis
Proposal
Icon

Industry

Pharmaceuticals

Icon

Sub Industry

Bulk Drug manufacturing

Icon

Open For Dilution

49 %

Icon

Top Customer

Icon

Ask

INR 35 Cr

Business Operation Information
Financial Information
2020 (in INR Cr) 2019 (in INR Cr) 2018 (in INR Cr) 2017 (in INR Cr)
Sales
N.D N.D N.D N.D
EBITDA
N.D N.D N.D N.D
PAT
N.D N.D N.D N.D
Business Documents